Trial Profile
A Randomized, Explorative, Double-Blind, Double-Dummy, Multi-Center, Parallel Group Study to Assess Sustainable Efficacy of Once Daily Vardenafil (10 mg) for 12 and 24 Weeks Versus Vardenafil PRN in Men With Mild or Mild to Moderate ED.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms RESTORE
- Sponsors Bayer
- 29 Aug 2012 New source identified and integrated (German Clinical Trials Register, DRKS00004098).
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 12 Jul 2011 Actual end date changed from 1 Jan 2007 to 20 Mar 2007 as reported by EudraCT.